stella
beta
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept. — Stella
Home
/
Kidney Transplant Infection
/
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
View on ClinicalTrials.gov
Recruiting
Back to Kidney Transplant Infection trials
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Trial locations
(1 site)
France
University Rouen Hospital, Rouen